Back to results
US 6,335,032 B1Granted
Orally administrable solid dosage form
Life of this patent
Estimating the term…
Abstract
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
Claims0
Claims aren’t available for this document.